BRIEF published on 12/13/2024 at 08:10, 1 year 3 months ago Nyxoah lance la thérapie Genio® en Angleterre Apnée Obstructive Du Sommeil Nyxoah SA Lancement Sur Le Marché Thérapie Genio® Service National De Santé D'Angleterre
BRIEF published on 12/13/2024 at 08:10, 1 year 3 months ago Nyxoah Launches Genio® Therapy in England NHS England Obstructive Sleep Apnea Nyxoah SA Market Launch Genio® Therapy
PRESS RELEASE published on 12/13/2024 at 08:05, 1 year 3 months ago Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England Nyxoah announces commercial launch of Genio Innovative Therapy in England with successful implants at UCLH. Genio system covered under NHS SSDP for OSA patients Nyxoah Genio Innovative Therapy England OSA
BRIEF published on 11/06/2024 at 22:10, 1 year 5 months ago Nyxoah publie ses résultats financiers du troisième trimestre 2024 Résultats Financiers Approbation De La FDA Situation De Trésorerie Apnée Obstructive Du Sommeil Commercialisation Aux États-Unis
BRIEF published on 11/06/2024 at 22:10, 1 year 5 months ago Nyxoah Reports Third Quarter 2024 Financial Results Financial Results Cash Position FDA Approval Obstructive Sleep Apnea U.S. Commercialization
PRESS RELEASE published on 11/06/2024 at 22:05, 1 year 5 months ago Nyxoah Reports Third Quarter Financial and Operating Results Nyxoah SA reports third quarter financial and operating results, with FDA approval on track for Q1 2025 and strengthening of U.S. commercial team. Company fully funded until mid-2026 Financial Results FDA Approval Sleep Apnea Nyxoah U.S. Commercial Team
BRIEF published on 10/08/2024 at 14:05, 1 year 6 months ago Nyxoah Secures $27 Million in At-the-Market Offering Financing U.S. Market Nyxoah Neuromodulation Healthcare Investor
BRIEF published on 10/08/2024 at 14:05, 1 year 6 months ago Nyxoah obtient 27 millions de dollars lors d'une offre sur le marché Financement Marché Américain Nyxoah Neuromodulation Investisseur Dans Le Secteur De La Santé
PRESS RELEASE published on 10/08/2024 at 14:00, 1 year 6 months ago Nyxoah Raises $27 Million through its At-the-Market Offering Nyxoah raises $27 million through its At-the-Market Offering, strengthening balance sheet and U.S. focus. New investment from U.S. healthcare investor Financing At-the-market Offering Nyxoah Obstructive Sleep Apnea Healthcare Investor
BRIEF published on 09/27/2024 at 22:35, 1 year 6 months ago Nyxoah présente les données prometteuses de l'étude DREAM à l'ISSS 2024 Approbation De La FDA Apnée Obstructive Du Sommeil Données Cliniques Étude DREAM Stimulation Génio
Published on 04/08/2026 at 23:00, 1 hour 20 minutes ago NXT Energy Solutions Announces SFD Survey Contract
Published on 04/08/2026 at 22:05, 2 hours 15 minutes ago GameSquare Achieves First Positive Adjusted EBITDA Quarter in Fourth Quarter, Marking Inflection to Operating Profitability
Published on 04/08/2026 at 18:45, 5 hours 35 minutes ago Nano One to Receive Additional C$4.3M from the Government of Canada to Advance Battery Material Production for Energy Security & Defence
Published on 04/08/2026 at 18:45, 5 hours 35 minutes ago Nano One recevra 4,3 M$ supplémentaires du gouvernement du Canada pour faire avancer la production de matériaux de batterie pour la sécurité énergétique et la défense
Published on 04/08/2026 at 16:08, 8 hours 12 minutes ago Super Copper Announces Investor Relations Agreement
Published on 04/08/2026 at 23:54, 26 minutes ago EQS-Adhoc: Raiffeisen Bank International AG: Raiffeisen Bank International AG announces its intention to launch a voluntary takeover offer to the shareholders of Addiko Bank AG
Published on 04/08/2026 at 23:30, 49 minutes ago AMPERA Officially Opens World Headquarters in Florida
Published on 04/08/2026 at 23:21, 58 minutes ago EQS-Adhoc: Raiffeisen Bank International AG: RBI announces intention to submit a voluntary public tender offer for all Addiko shares at EUR 23.05 per share
Published on 04/08/2026 at 21:03, 3 hours 16 minutes ago EQS-Adhoc: Elmos Semiconductor SE: Cancellation of 540,000 treasury shares (approx. 3.05% of the share capital)
Published on 04/08/2026 at 18:10, 6 hours 10 minutes ago PolyPeptide announces results of the annual General Meeting 2026
Published on 04/08/2026 at 18:17, 6 hours 2 minutes ago Mise à disposition du Rapport sur la solvabilité et la situation financière 2025 du Groupe des Assurances du Crédit Mutuel
Published on 04/08/2026 at 18:16, 6 hours 3 minutes ago Mise à disposition des états financiers 2025 du Groupe des Assurances du Crédit Mutuel
Published on 04/08/2026 at 18:02, 6 hours 18 minutes ago Publication of the 2025 Universal Registration Document
Published on 04/08/2026 at 18:02, 6 hours 18 minutes ago Mise à disposition du Document d'Enregistrement Universel 2025
Published on 04/08/2026 at 17:45, 6 hours 35 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
